Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Replacement Directors Holdings & TVR

18 Feb 2015 17:04

RNS Number : 2877F
WANdisco Plc
18 February 2015
ย 

๏ปฟ

ย 

The following amendment has been made to the 'Directors Holdings and Total Voting Rights' announcement released on 18th February 2015 at 08.38 under RNS No 2088F.

ย 

Jim Campigli holds 1,544,143 shares not 1,846,143 as previously stated.

ย 

All other details remain unchanged.

ย 

The full amended text is shown below.

ย 

ย 

18 February 2015

WANdisco plc

ย 

Directors Holdings and Total Voting Rights

ย 

The board of directors of WANdisco plc ("WANdisco" or the "Company") (AIM: WAND) (the "Directors"), the leading provider of non-stop Big Data, has been advised that pursuant to the Placing, the Directors have the following Ordinary Shares and holdings in the Company:

ย 

Number of Ordinary Shares

Percentage of Ordinary Shares

David Richards

2,783,153

9.5%

Paul Harrison

70,285

0.2%

Jim Campigli

1,544,143

5.3%

Paul Walker

111,111

0.4%

ย 

The total number of Ordinary Shares in issue with voting rights is 29,235,769 Ordinary Shares of ten pence each.

ย 

No Ordinary Shares are held in treasury.

ย 

Capitalised terms defined in the Company's announcement of 23 January 2015 shall have the same meanings in this announcement unless the context otherwise requires.

ย 

Enquiries:

ย 

WANdisco plc

David Richards, Chief Executive Officer

Paul Harrison, Chief Financial Officer

Phil Branston, VP Corporate Development & Investor Relations

via FTI Consulting

Investec Bank plc - Nominated Adviser and Joint Broker

Christopher Baird / Dominic Emery

+44 (0) 20 7597 4000

UBS Investment Bank - Joint Broker

Rahul Luthra / Sandip Dhillon

+44 (0) 20 7567 8000

FTI Consulting - PR Adviser to WANdisco

+44 (0) 20 3727 1000

Matt Dixon / Rob Mindell

ย 

This information is provided by RNS
The company news service from the London Stock Exchange
ย 
END
ย 
ย 
MSCGGUGUPUPAGMR
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.